Načítá se...
Adjunctive aripiprazole in risperidone-induced hyperprolactinaemia: double-blind, randomised, placebo-controlled trial
BACKGROUND: Hyperprolactinaemia is a troublesome side-effect of treatment with antipsychotics. AIMS: This double-blind, placebo-controlled study aimed at examining the effect of adjunctive treatment with 10 mg aripiprazole on prolactin levels and sexual side-effects in patients with schizophrenia sy...
Uloženo v:
| Vydáno v: | BJPsych Open |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
The Royal College of Psychiatrists
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4998932/ https://ncbi.nlm.nih.gov/pubmed/27703744 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1192/bjpo.bp.115.001248 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|